AVID Medical, Inc. appears in FDA device enforcement records as the recalling firm for five Class II recalls, with center classification dates between October 7 and November 5, 2026. Four records list September 8, 2026 as the initiation date; the Robotic Prostatectomy Pack record lists August 10, 2026. The records list the firm at 9000 Westmont Dr, Toano, Virginia, which is a filing address rather than a verified headquarters. Four of the five records carry Halyard product descriptions: the ARTHROSCOPY PACK (SAMM014-21), the MINOR PACK (VASF105-08) and two ANTERIOR HIP PACK configurations (SOAH30 and SOAH31). The fifth covers a ROBOTIC PROSTATECTOMY PACK (NAMC423-11) whose record does not name a brand. Each recall is voluntary and firm initiated, with e-mail as the initial notification method. [1][2][3][4][5]

Documented kit identities and lot-level scope

The FDA records identify each affected product by catalog or item number, UDI-DI and lot. The Arthroscopy Pack record lists SAMM014-21, UDI-DI 10809160515600 and lot 1698318 with an expiration date of December 3, 2026, covering 17 kits. The Minor Pack record lists VASF105-08, UDI-DI 10809160451960 and lot 1659384 expiring September 30, 2027, covering 108 kits. The two Anterior Hip Pack records list SOAH30 with lots 1705826 and 1705827 (80 kits) and SOAH31 with lot 1689215 (56 kits). The Robotic Prostatectomy Pack record lists NAMC423-11, UDI-DI 10809160490808 and kit lot 1671502, with a recalled supplier component A119216M and supplier lot NGKT2404, with a recorded product quantity of 6 and no unit designation. [1][2][3][4][5]

Distribution statements differ by record. The Arthroscopy Pack record describes nationwide distribution in the state of Texas; the Minor Pack record a nationwide distributor in Illinois; both Anterior Hip Pack records a nationwide distributor in Arizona; and the Robotic Prostatectomy Pack record nationwide distribution in Arizona, California, Florida, Maryland, Nebraska and Texas. These are the distribution patterns stated in the filings, not a measure of total company reach. [1][2][3][4][5]

Stated recall reasons

The Arthroscopy Pack recall reason is a shelf label mislabeled as "Extremity" instead of "Arthroscopy Pack." The Minor Pack recall cites the potential for open seals on header bags, compromising sterility. Both Anterior Hip Pack records state that a non-sterile component was piggybacked and incorrectly placed outside of the sterile barrier and not subjected to EO sterilization per kit specifications. The Robotic Prostatectomy Pack record states the product may be potentially contaminated with a lubricant used during the manufacturing process. [1][2][3][4][5]

One FDA record adds a root cause description of process control for the Arthroscopy Pack event and describes the firm's action: consignees were notified on or about September 8, 2026 by e-mail with an "URGENT: MEDICAL DEVICE FIELD CORRECTION" letter, instructing them to segregate and quarantine affected product, apply a corrected shelf label to affected kits in inventory, and notify downstream consignees if units were further distributed. The same record lists firm FEI number 1047429. [7]

How the filings are indexed

The FDA recall database entry for the Halyard ARTHROSCOPY PACK is a Class 2 device recall page, consistent with the enforcement record's Class II classification. A third-party summary describes the Arthroscopy Pack event as posted November 5, 2026 and rated moderate risk, restating the mislabeling reason and the 17-kit quantity, and identifies the FDA notice as its primary source. [6][10]

The FDA device recall query covering event dates posted November 5 through November 11, 2026 returns the AVID Medical Arthroscopy Pack entry alongside unrelated records, including a LIAISON PLEX Gram-Negative Blood Culture Assay entry under a different recall number. The AVID Medical records in this set are therefore a subset of a broader posting window, not a complete account of the firm's history. [7]

What the records do not establish

The filings do not state the company's ownership, corporate parent, website, customer list, certifications or manufacturing capacity. The Toano, Virginia address appears as the recalling firm's filing address and should not be read as a verified headquarters. The records also do not establish clinical performance of any kit or the resolution status beyond the "Ongoing" status shown for each recall. [1][2][3][4][5]